Award
National Institute on Aging 5R01AG081237-04
Transcranial Magnetic Stimulation for MCI: A Phase II Dose-Response Study
Recipient
National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services
Award Amount
$748,467.00
Ceiling
$748,467.00
Awarded
June 03, 2026
Identifier
5R01AG081237-04
A phase II clinical trial funded by NIH/NIA to study dose-response of non-invasive brain stimulation in Mild Cognitive Impairment patients, aiming to optimize treatment and prevent dementia.
Description
This project involves a phase II clinical trial to determine the dose-response relationship of non-invasive brain stimulation (iTBS-rTMS) in patients with Mild Cognitive Impairment (MCI). The study aims to optimize treatment for depression and cognitive function, potentially preventing dementia. The trial will include 48 participants, randomized across six dose levels, with assessments at multiple time points. The funding is provided by the NIH/NIA, with a total award amount of $748,467.